CLINICAL TRIALS

Phase 3 clinical trial: Bharat Biotech says COVID-19 vaccine shows 81% interim efficacy

Bharat Biotech's homegrown COVID-19 vaccine has shown an interim vaccine efficacy of 81% in late-stage clinical trials, the Indian company ...

In boost for COVID-19 battle, Pfizer vaccine found 94% effective in real world

The research in Israel - two months into one of the world's fastest rollouts, providing a rich source of data - showed two doses of the Pfi...

Kochi firm PNB Vesper Life Sciences completes phase 2 clinical trial of coronavirus drug

The company on Monday said the clinical trial was initiated in November at BJ Government Medical College and Sassoon General Hospital in Pu...

China approves 16 locally-made COVID-19 vaccines for clinical trials

China has already given conditional approval to two inactivated COVID-19 vaccines made by state-owned developers -- Sinopharm and Sinovac B...

Fear over Covaxin unfounded, Harsh Vardhan tells Chhattisgarh

In response to Chhattisgarh health minister's letter, health minister says vaccines are safe; vials have expiration date. ET had first repo...

China says 16 Chinese COVID-19 vaccines undergoing clinical trials

China is conducting clinical trials of 16 COVID-19 vaccines, seven of which have entered phase-III trials and one has conditionally hit the...

Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine

"Based on the safety and immunogenicity data of the phase 1 clinical trial, the company would be given permission for conducting phase 2 cl...

People with fever, pregnant and breastfeeding women avoid Covaxin, says Bharat Biotech

The vaccine maker in the fact sheet on Covaxin, posted in its website, said the clinical efficacy of the vaccine is yet to be established a...

Bharat Biotech to pay compensation if Covaxin causes side effects

"The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vacci...

Covid vaccination drive: Bharat Biotech to pay compensation if Covaxin causes side effects

Bharat Biotech, which has received a government purchase order for supply of 55 lakh doses of Covaxin, a COVID-19 vaccine, said the company...

A great milestone in India's scientific capability: Bharat Biotech on approval for emergency use of Covaxin

The approval of Covaxin for emergency use is a giant leap for innovation and novel product development in India, Krishna Ella, Chairman and...

Bharat Biotech on course to have 26,000 volunteers for Phase-3 clinical trials of Covaxin

The company statement has come after an expert panel of India's central drug authority recommended granting permission for restricted use o...

Zydus Cadila seeks govt nod to start Phase-III clinical trials of COVID-19 vaccine

The Phase-II study of the vaccine, ZyCoV-D, had been conducted in over 1,000 healthy adult volunteers as part of the adaptive Phase-I and I...

Bharat Biotech's Covaxin shows encouraging results in clinical trials: Research paper

In a double-blind, randomised, multi-centre phase 2 clinical trials, a total of 380 healthy children and adults were randomised and adminis...

COVID-19: Randomised clinical trial on efficacy of Siddha medicine completed

Nine other clinical trials involving Siddha medicine either as stand-alone or adjunct with allopathic medicine that were taken up throughou...

Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1

Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical...

Phase-3 clinical trial of Covaxin commences in Kolkata

The governor further said that the Centre's Ayushman Bharat scheme, which provides free healthcare services, has provided succour to many a...